Adapthealth ( (AHCO) ) has released its Q1 earnings. Here is a breakdown of the information Adapthealth presented to its investors.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
AdaptHealth Corp. is a leading provider of healthcare-at-home solutions, offering home medical equipment, medical supplies, and related services across the United States. The company operates in four segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home, serving approximately 4.2 million patients annually.
In its first quarter of 2025, AdaptHealth reported a slight decline in net revenue to $777.9 million, a 1.8% decrease from the previous year. The company also experienced a net loss of $7.2 million, compared to a $2.1 million loss in the same period last year. Despite these challenges, the company saw an improvement in cash flow from operations, which increased to $95.5 million from $49.0 million.
Key financial metrics highlighted a decrease in Adjusted EBITDA by 19.3% to $127.9 million. However, the company managed to improve its free cash flow position, reducing its negative free cash flow to $0.1 million from $38.9 million. Additionally, AdaptHealth completed the sale of certain incontinence and infusion assets, which is expected to impact future financial performance.
Looking ahead, AdaptHealth has adjusted its financial guidance for 2025, projecting net revenue between $3.18 billion and $3.32 billion and Adjusted EBITDA between $665 million and $705 million. The company remains focused on leveraging its operational scale and geographic reach to drive sustainable growth across its segments.
AdaptHealth’s management remains optimistic about the future, emphasizing their commitment to improving financial performance and capturing market share through enhanced patient service and strategic asset dispositions.